SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-13-001620
Filing Date
2013-08-14
Accepted
2013-08-14 17:49:54
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 vsta10qjune302013.htm 10-Q 980618
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(A) UNDE ex31-1.htm EX-31.1 9019
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER REQUIRED BY RULE 13A-14(A) UNDE ex31-2.htm EX-31.2 9063
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS REQUIRED BY RULE ex32.htm EX-32 6219
  Complete submission text file 0001415889-13-001620.txt   8312395

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vsta-20130630.xsd EX-101.SCH 62444
6 XBRL INSTANCE DOCUMENT vsta-20130630.xml EX-101.INS 839444
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsta-20130630_pre.xml EX-101.PRE 205389
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsta-20130630_lab.xml EX-101.LAB 297883
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsta-20130630_def.xml EX-101.DEF 109316
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsta-20130630_cal.xml EX-101.CAL 52913
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54014 | Film No.: 131039024
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences